JON GRIGG: Open Payments
NPI 1720168727 · MANSFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 29 payments from 5 companies in 2025. Trend: 2023 $297 · 2024 $581 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 21 | $284 |
| Neurocrine BioSciences, Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
Products named: Qelbree, INGREZZA, AUSTEDO XR, COBENFY, LYBALVI.
Industry payments across PA — which companies pay providers there.
